InicioCarterasWatchlistComunidadDescubreScreener
NOT FOR DISTRIBUTION

Integrated Research Limited

Informe acción ASX:IRI

Capitalización de mercado: AU$51.5m

  • Resumen empresa
  • Valoración
  • Crecimiento Futuro
  • Rendimiento pasado
  • Salud Financiera
  • Dividendos
  • Dirección
  • Propiedad
  • Información adicional
  • Comunidad de acciones

Integrated Research Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Ian Lowe

Chief Executive Officer (CEO)

AU$753.2k

Compensación total

Porcentaje del salario del CEO71.11%
Permanencia del CEO1.9yrs
Participación del CEOn/a
Permanencia media de la dirección2.1yrs
Promedio de permanencia en la Junta Directiva2.8yrs

Actualizaciones recientes de la dirección

Recent updates

Artículo de análisis • Jul 14

Why Integrated Research Limited (ASX:IRI) Could Be Worth Watching

Integrated Research Limited ( ASX:IRI ), might not be a large cap stock, but it saw a decent share price growth of 11...
User avatar
Actualización de narrativa • Jun 25

IRI: New AI Observability Offerings Will Support Future Upside

Analysts have kept their A$0.36 price target for Integrated Research unchanged, citing only very small adjustments to inputs such as the discount rate, long run revenue growth, profit margin and future P/E assumptions. What’s in the News for Integrated Research Integrated Research announced Iris for Card Payments, an AI powered assistant built on the Prognosis observability platform that uses natural language prompts to provide real time card payments insights.
User avatar
Actualización de narrativa • Jun 08

IRI: Product Vision Day And Steady Assumptions Will Support Future Upside

Analysts have reiterated an A$0.36 fair value for Integrated Research, with only minor tweaks to the discount rate, revenue growth, profit margin and forward P/E assumptions. This signals that their updated modelling leaves the overall valuation view broadly intact.
User avatar
Actualización de narrativa • May 24

IRI: Product Vision Day And Stable Assumptions Will Support Long Term Upside

Analysts have maintained their A$0.36 price target for Integrated Research, noting that only minor adjustments to the discount rate, revenue growth, profit margin and forward P/E assumptions were made and that these did not materially change their valuation view. What's in the News Integrated Research scheduled an Analyst and Investor Day focused on outlining its product vision and innovation strategy (Key Developments).
User avatar
Actualización de narrativa • Apr 20

IRI: Product Vision Day And Stable Assumptions Will Support Long Term Upside

Analysts have kept their fair value estimate for Integrated Research steady at A$0.36. Only small technical adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions informed the updated price target stance.
User avatar
Actualización de narrativa • Apr 05

IRI: Product Vision Day And Stable Assumptions Will Support Long Term Upside

Analysts have kept the A$ price target for Integrated Research broadly unchanged, with only a marginal adjustment that reflects slightly updated assumptions for discount rate, revenue growth, profit margins and future P/E multiples. What's in the News Integrated Research has scheduled an Analyst/Investor Day focused on outlining its product vision for the business.
User avatar
Actualización de narrativa • Mar 22

IRI: Steady Assumptions And Product Vision Update Will Support Long Term Upside

Analysts have kept the price target for Integrated Research steady at A$0.36, citing only minor tweaks to inputs such as the discount rate, revenue growth, profit margin and future P/E assumptions, rather than any major shift in the outlook. What's in the News Integrated Research has scheduled an Analyst and Investor Day, giving you a chance to hear directly from management about the business and its direction (company event filing).
User avatar
Actualización de narrativa • Mar 08

IRI: Revised Margins And P/E Assumptions Will Support Long Term Upside

Analysts have trimmed their fair value estimate for Integrated Research from A$0.40 to A$0.36. This reflects updated assumptions that pair a slightly higher discount rate and future P/E multiple with more cautious profit margin expectations and revised revenue growth forecasts.
User avatar
Actualización de narrativa • Feb 21

IRI: New AI Observability Capabilities Will Support Long Term Upside Potential

Analysts have slightly trimmed their price target for Integrated Research to A$0.40, reflecting small updates to discount rate assumptions and expected future P/E, while keeping fair value and key operating assumptions broadly unchanged. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer for multi vendor unified communications and collaboration observability, built on the company’s Prognosis platform.
User avatar
Actualización de narrativa • Feb 06

IRI: New AI Observability Platform Will Support Long Term Upside

Analysts have adjusted their price target for Integrated Research to account for a slightly higher discount rate and a modestly revised future P/E expectation, resulting in a small change in estimated valuation levels. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer for multi vendor unified communications and collaboration observability, built on the company’s Prognosis platform and designed to turn complex monitoring data into plain language answers for IT teams and business users.
Artículo de análisis • Feb 06

Is Now The Time To Look At Buying Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it saw a decent share price growth...
User avatar
Actualización de narrativa • Jan 23

IRI: New AI Observability Layer Will Support Long Term Upside

Analysts have made only a marginal adjustment to their price target for Integrated Research, reflecting slightly updated views on discount rates, long term revenue growth, profit margins, and the future P/E multiple, while keeping their fair value estimate broadly in line with prior assumptions. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer embedded in its Prognosis platform, designed to turn complex observability data from unified communications and collaboration environments into plain language insights for IT and business users.
User avatar
Actualización de narrativa • Jan 08

IRI: Cloud Observability Services And AI Features Will Support Long Term Upside

Analysts have kept their fair value estimate for Integrated Research broadly steady, making only minor tweaks to inputs such as discount rate, revenue growth, profit margin and future P/E. These changes feed into a small adjustment in the overall price target and reflect a largely unchanged view of the company’s medium term risk and earnings profile.
User avatar
Actualización de narrativa • Dec 17

IRI: Cloud Observability Expansion Is Expected To Support Long Term Upside

Analysts have modestly raised their integrated research price target, citing incremental adjustments to discount rate assumptions and forward valuation multiples that support a fair value estimate now framed around improved long term earnings visibility. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer embedded in its Prognosis observability platform.
User avatar
Actualización de narrativa • Dec 02

IRI: New Cloud Platform Launch Is Expected To Drive Future Upside

Analysts have slightly reduced their price target for Integrated Research, reflecting minor adjustments in discount rate and future price-to-earnings assumptions. Key financial projections remain essentially unchanged.
User avatar
Actualización de narrativa • Nov 18

IRI: Revenue Setbacks Will Be Outweighed By New Platform Launch

Analysts have revised their price target for Integrated Research downward from $0.55 to $0.40. They cite lowered revenue growth projections and compressed profit margins as the primary factors behind the adjustment.
Artículo de análisis • Nov 14

Integrated Research Limited's (ASX:IRI) Prospects Need A Boost To Lift Shares

Integrated Research Limited's ( ASX:IRI ) price-to-earnings (or "P/E") ratio of 4.1x might make it look like a strong...
Artículo de análisis • Aug 30

Integrated Research (ASX:IRI) Is Paying Out A Dividend Of A$0.02

The board of Integrated Research Limited ( ASX:IRI ) has announced that it will pay a dividend on the 21st of October...
User avatar
Actualización de narrativa • Aug 27

Revenue May Stabilize While Profit Margins Decline In The Coming Years

Despite a notable increase in consensus revenue growth forecasts, a sharp decline in the future P/E multiple has driven the consensus analyst price target for Integrated Research down from A$0.70 to A$0.55. What's in the News Integrated Research previewed enhanced Cisco cloud migration solutions at Cisco Live, offering deeper visibility, real-time and intelligent insights.
Artículo de análisis • Aug 11

Some Investors May Be Worried About Integrated Research's (ASX:IRI) Returns On Capital

ASX:IRI 1 Year Share Price vs Fair Value Explore Integrated Research's Fair Values from the Community and select yours...
Artículo de análisis • Jun 16

When Should You Buy Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it saw a double-digit share price...
Artículo de análisis • May 09

Integrated Research Limited (ASX:IRI) Shares Fly 29% But Investors Aren't Buying For Growth

Integrated Research Limited ( ASX:IRI ) shareholders would be excited to see that the share price has had a great...
User avatar
Nueva narrativa • Feb 09

Shifting To High-Value Clients And Launching IR Labs May Improve Stability, But Challenges Remain

Strategic focus on high-value enterprise customers and efficient cost management is expected to enhance net margins and revenue stability.
Artículo de análisis • Oct 22

Why Integrated Research Limited (ASX:IRI) Could Be Worth Watching

Integrated Research Limited ( ASX:IRI ), might not be a large cap stock, but it saw a decent share price growth of 17...
Artículo de análisis • Aug 29

Impressive Earnings May Not Tell The Whole Story For Integrated Research (ASX:IRI)

Last week's profit announcement from Integrated Research Limited ( ASX:IRI ) was underwhelming for investors, despite...
Artículo de análisis • Aug 21

Investors Don't See Light At End Of Integrated Research Limited's (ASX:IRI) Tunnel And Push Stock Down 37%

Integrated Research Limited ( ASX:IRI ) shares have had a horrible month, losing 37% after a relatively good period...
Artículo de análisis • Jun 28

Integrated Research Limited (ASX:IRI) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Despite an already strong run, Integrated Research Limited ( ASX:IRI ) shares have been powering on, with a gain of 33...
Artículo de análisis • Jun 11

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

If we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? When we...
Artículo de análisis • Apr 20

Why Investors Shouldn't Be Surprised By Integrated Research Limited's (ASX:IRI) Low P/S

Integrated Research Limited's ( ASX:IRI ) price-to-sales (or "P/S") ratio of 0.8x might make it look like a buy right...
Artículo de análisis • Mar 02

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Artículo de análisis • Dec 27

Is It Time To Consider Buying Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it saw a decent share price growth...
Artículo de análisis • Nov 21

A Look At The Intrinsic Value Of Integrated Research Limited (ASX:IRI)

Key Insights Using the Dividend Discount Model, Integrated Research fair value estimate is AU$0.30 Integrated...
Artículo de análisis • Aug 28

Is Integrated Research Limited (ASX:IRI) Potentially Undervalued?

While Integrated Research Limited ( ASX:IRI ) might not be the most widely known stock at the moment, it received a lot...
Artículo de análisis • May 12

What Is Integrated Research Limited's (ASX:IRI) Share Price Doing?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it received a lot of attention from...
Artículo de análisis • Jan 11

Is It Time To Consider Buying Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), might not be a large cap stock, but it received a lot of attention from a...
Artículo de análisis • Nov 24

A Look At The Intrinsic Value Of Integrated Research Limited (ASX:IRI)

Today we will run through one way of estimating the intrinsic value of Integrated Research Limited ( ASX:IRI ) by...

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Ian Lowe en comparación con los beneficios de Integrated Research?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2026AU$753kAU$536k

AU$1m

Mar 31 2026n/an/a

AU$4m

Dec 31 2025n/an/a

AU$7m

Sep 30 2025n/an/a

AU$10m

Jun 30 2025AU$639kAU$385k

AU$13m

Compensación vs. Mercado: La compensación total de Ian($USD540.25K) está por encima de la media de empresas de tamaño similar en el mercado Australian ($USD339.91K).

Compensación vs. Ingresos: La compensación de Ian ha sido consistente con los resultados de la empresa en el último año.


CEO

Ian Lowe (56 yo)

1.9yrs
Permanencia
AU$753,158
Compensación

Mr. Ian Lowe, ASCM, is Chief Executive Officer of Integrated Research Limited from October 1, 2024 and also serves as its Director since October 17, 2024 and serves as its Managing Director since 2024. Mr....


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Ian Lowe
CEO, MD & Director1.9yrsAU$753.16ksin datos
Christian Shaw
Chief Financial Officer2.5yrsAU$557.99ksin datos
Michael Tomkins
Chief Technology Officer7yrssin datossin datos
Gemma Garkut
Head of Communications & IRno datasin datossin datos
Marco Cantamessi
Senior Vice President of Global Sales2.1yrssin datossin datos
Geoff Sieron
Senior Vice President of IR Labs2.1yrssin datossin datos
Elie Shuggi
Chief Product Officer1.7yrssin datossin datos
Leanne Ralph
Company Secretary1.8yrssin datossin datos
2.1yrs
Permanencia media

Equipo directivo experimentado: El equipo directivo de IRI se considera experimentado (2.1 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Ian Lowe
CEO, MD & Director1.9yrsAU$753.16ksin datos
Mark Ronald Brayan
Independent Non-Executive Director2.8yrsAU$103.00k0.14%
A$ 74.1k
Peter Lloyd
Independent Non-Executive Chairman16.2yrsAU$185.40ksin datos
Katherine Greenhill
Independent Non-Executive Director2.4yrsAU$103.00k0.050%
A$ 25.7k
Michael Hitz
Independent Non-Executive Director2.9yrsAU$103.00k0.17%
A$ 85.5k
2.8yrs
Permanencia media
62yo
Promedio de edad

Junta con experiencia: La junta directiva de IRI no se considera experimentada (2.8 años de permanencia promedio), lo que sugiere una nueva junta directiva.


Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/09/12 19:37
Precio de las acciones al final del día2026/09/10 00:00
Beneficios2026/06/30
Ingresos anuales2026/06/30

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
  • Formulario SEC 10-K
  • Formulario SEC 10-Q
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
  • Informes de análisis
  • Blue Matrix
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
  • Datos de mercado ICE
  • Formulario S-1 de la SEC
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
  • Formulario SEC 4
  • Formulario SEC 13D
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
  • Formulario SEC 10-K
  • Formulario SEC DEF 14A
Principales avances10 años
  • Anuncios de empresas
  • Formulario SEC 8-K

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Integrated Research Limited está cubierta por 4 analistas. 1 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Chris SavageBell Potter
Katie BelleLodge Partners Pty Ltd.
Todd GuyotMA Moelis Australia Securities Pty Ltd

Toma mejores decisiones de inversión en cualquier lugar

Escanea para descargar
Abrir AppStoreAbrir Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Ver fuentes de datos
Mercados
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Ideas de inversión
  • Empresas infravaloradas
  • Potentes generadores de dividendos
  • Compras con información privilegiada
  • Energía nuclear
  • Vehículos autónomos
  • Inteligencia artificial
  • Criptomonedas y blockchain
  • Ciberseguridad
  • Más ideas
Comunidades de acciones
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Herramientas y funciones
  • Seguimiento de la cartera
  • Buscador de valores y alertas
  • Narrativas y Valores de Feria
  • Calculadora de dividendos
Noticias y descubrimientos
  • Últimas noticias de stock
  • Incidencias del mercado global
  • El Foxhole
  • Ideas de inversión
  • Narrativas de la comunidad
  • Qué hay de nuevo
Simply Wall St
  • Planes y precios
  • Publicidad
  • Quiénes somos
  • Contacte con nosotros
  • Empleos
  • Centro de ayuda
  • Aprender a invertir en bolsa
  • Programa de afiliados
  • Empresas y negocios
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Términos y condiciones de uso
  • Política de privacidad
  • Términos de IA
  • Guía de servicios financieros